期刊文献+

依达拉奉对肺缺血再灌注损伤保护作用的实验研究 被引量:26

Protection of edaravone against lung ischemia reperfusion injury in rabbits
下载PDF
导出
摘要 目的:通过建立兔在体肺热缺血再灌注模型,探讨依达拉奉对兔实验性肺缺血再灌注损伤的影响及作用机制。方法:采用兔肺原位热缺血再灌注损伤模型进行研究。24只大白兔随机分为三组:①对照组(C组,n=8),开胸后不阻断肺门,静脉缓慢推注生理盐水5 ml/kg;②缺血再灌注组(I/R组,n=8),左肺接受60 min的缺血,然后接受60 min再灌注,于缺血前5 min静脉缓慢推注生理盐水5 ml/kg;③依达拉奉干预组(E组,n=8),于缺血前5 min静脉缓慢推注依达拉奉10 mg/kg(5 ml/kg),左肺接受60 min的缺血,然后接受60 min再灌注。120 min实验结束时,留取各组动物血液标本,测定血浆丙二醛(MDA)含量及超氧化物歧化酶(SOD)活性;收集支气管肺泡灌洗液(BALF),检测支气管肺泡灌洗液中白细胞计数、中性粒细胞百分比及肺通透性指数;留取肺组织标本,测定肺组织湿、干重量,计算干/湿重比(D/W)及行肺组织病理检查。结果:I/R组血浆丙二醛含量、支气管肺泡灌洗液中蛋白含量、支气管肺泡灌洗液中WBC总数及中性粒细胞百分比明显高于C组及E组(P<0.01),E组与C组比较,无统计学意义(P>0.05);I/R组血浆SOD活性、血清蛋白含量及肺组织干/湿重比(D/W)较C组及E组显著降低(P<0.05),E组与C组比较,无统计学意义(P>0.05);肺通透指数I/R组明显高于E组与C组(P<0.01),E组显著高于C组(P<0.05);肺组织病理显示,E组肺泡内出血、炎性细胞浸润、渗出及间质水肿均较I/R组为轻。结论:依达拉奉通过清除氧自由基、抑制脂质过氧化,对兔肺原位热缺血再灌注损伤有一定保护作用。 Objective: To investigate whether or not edaravone has an effect on reducing lung isehemiarepetfusion injury in rabbits. Methods: Twenty-four rabbits were randomly divided into three groups: ① the control group(group C, n = 8): received stemotomy only and no ischemia; ② the ischemia/repeffusion group(group I/R, n = 8) : the left lungs of rabbits were rendered ischemia by ligating the left pulmonary hili for 60 minutes followedby 60 minutes repeffusion; ③ the edaravone group(group E, n = 8) : the left lungs were rendered ischemia for 60 minutes followed by 60 minutes reperfusion, and 10 mg/kg edaravone was administered intravenously 5 minutes prior to ischemia. Blood MDA and SOD were measured. Protein concentrations, WBC count, and PMN percentage in broncho-alveolar lavage fluid were determined. Samples of left lung tissue were sent for determining the left lung dry-to-wet weight ratio and evaluating the pathologic changes. Results: Blood MDA level, protein concentrations, WBC count and PMN percentage in bronchoalveolar lavage fluid of group I/R were significantly higher than those of group C and group E( P 〈 0.01 ), and there was not significant difference between group C and group E ( P 〉 0.05) ; serum SOD activity, serum albumin concentration and left lung dry-to-wet ratio of of group I/R were significantly lower than those of group C and group E( P 〈 0.05), and there was not significant difference between group C and group E ( P 〉 0.05) ; the pulmonary permeability index of group I/R was significantly higher than that of group C and group E( P 〈 0.01 ); pathologic evaluations revealed mild alterations in alveolar structure, less white blood cell infiltration and less interstitial edema in group E than in group I/R. Conclusions: This study suggests that intravenous edaravone prior to ischemia attenuates the lung ischemia reperfusion injury in rabbits through its radical scavenging and antioxidant action.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第2期130-134,共5页 Journal of Shandong University:Health Sciences
关键词 依达拉奉 氧自由基 缺血再灌注损伤 Edaravone Oxygen free radicals Ischemia reperfusion injury
  • 相关文献

参考文献13

  • 1Alam S,Chan KM.Noninfectious pulmonary complications after organ transplantation[J].Curr Opin Pulm Med,1996,2(5):412-418.
  • 2Sekido N,Mukaida A,Harada A,et al.Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8[J].Nature,1993,365 (6447):654-657.
  • 3朱述阳,何冰.氧自由基在兔肺缺血再灌注损伤发生中的作用[J].中华医学杂志,1992,72(6):370-371. 被引量:5
  • 4常天辉,章新华,邢军,王怀良,刘晓阳.白花前胡及前胡甲素对心肌缺血再灌注大鼠IL-6水平及Fas、bax、bcl-2蛋白表达的影响[J].中国医科大学学报,2003,32(1):1-3. 被引量:50
  • 5Cakir O,Oruc A,Kaya S,et al.N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest[J].J Card Surg,2004,19(3):221-225.
  • 6Zheng JH,Xu ZW,Wang W,et al.Lung perfusion with oxygenated blood during aortic clamping prevents lung injury[J].Asian Cardiovasc Thorac Ann,2004,12(1):58-60.
  • 7杨政,吴玉林.治疗急性脑梗死的新型脑保护药依达拉奉[J].中国新药杂志,2002,11(12):911-913. 被引量:352
  • 8Abe T,Unno M,Takeuchi H,et al.A new free radical scavenger,edaravone,meliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo[J].J Gastrointest Surg,2004,8(5):604-615.
  • 9Tomatsuri N,Yoshida N,Takagi T,et al.Edaravone,a newly developed radical scavenger,protects against ischemiareperfusion injury of the small intestine in rats[J].Int J Mol Med,2004,13(1):105-109.
  • 10Yamawaki M,Sasaki N,Shimoyama M,et al.Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes[J].Br J Pharmacol,2004,142(3):618-626.

二级参考文献13

  • 1王丽娟,李金鸣,常天辉,郝丽英,王玉萍,张克义.白花前胡甲素对豚鼠心室肌单细胞迟发性外向钾电流的影响[J].中国药理学与毒理学杂志,1995,9(3):192-195. 被引量:14
  • 2横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
  • 3Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
  • 4Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
  • 5Tabrizchi R.Edaravone Mitsubishi-Tokyo[J].Curr Opin Investig Drugs,2000,1(3)∶347-454.
  • 6Yamamoto T,Yuki S,Watanabe T,et al.Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia[J].Brain Res,1997,762(12)∶240-242.
  • 7Watanabe T,Egawa M.Effects of an antistroke agent MCI-186 on cerebral arachidonate cascades[J].J Pharmacol Exp Ther,1994,271(3)∶1624-1629.
  • 8Watanabe T,Morita I,Nishi H,et al.Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro[J].Prostaglandins Leukotrienes Essent Fatty Acids,1998,33(1)∶81-87.
  • 9Mitsumori K,Sakuragi M,Kitami K,et al.The effect MCI-186 on regional cerebral blood flow in patients with acute cerebral infarction-A sequential SPECT study[J].Ther Res,1998,19(4)∶1333-1345.
  • 10山本美奈子 高松康雄.Pharmacokinetic studies of 3—methyl—1—phenyl—2—pyrazolin—5—one(MCI—186):protein binding and distribution to red blood cell[J].药理と治疗,1997,25(17):1755-1763.

共引文献404

同被引文献242

引证文献26

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部